image
Kezar Life Sciences, Inc. KZR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.46
-0.798 %
$ 54.4 M
Market Cap
-0.55
P/E
BALANCE SHEET
221 M ASSETS
-26.15%
Growth Rates
1Year -26.15%
3Years 13.37%
5Years 14.04%
7Years 52.71%
10Years 0.00%
33.7 M LIABILITIES
13.37%
Growth Rates
1Year 13.37%
3Years 45.79%
5Years 41.74%
7Years 2.23%
10Years 0.00%
188 M EQUITY
-30.50%
Growth Rates
1Year -30.50%
3Years 9.99%
5Years 11.51%
7Years 43.88%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Kezar Life Sciences, Inc.
image
Current Assets 207 M
Cash & Short-Term Investments 201 M
Receivables 0
Other Current Assets 5.58 M
Non-Current Assets 14.3 M
Long-Term Investments 0
PP&E 8.69 M
Other Non-Current Assets 5.6 M
Current Liabilities 17.7 M
Accounts Payable 8.25 M
Short-Term Debt 6.02 M
Other Current Liabilities 3.47 M
Non-Current Liabilities 15.9 M
Long-Term Debt 15.9 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 35.5 40.5 62.9 21.2 15.0 24.2 51.0 9.7
Short Term Investments 165.9 236.1 145.5 119.2 63.3 83.2 0 0
Receivables 0 0 0 0 0 0 0 0
Inventory 0 0 2.5 2.0 1.2 0 0 0
Other Current Assets 5.6 9.2 3.3 4.4 2.9 2.4 1.3 0.7
Total Current Assets 206.9 285.7 211.7 144.8 81.1 109.8 52.3 10.5
PP&E 8.7 13.2 6.0 6.7 8.1 4.6 1.5 0.9
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 13 K 13 K
Other Long Term Assets 5.6 0.7 0.3 0.3 0.3 0.3 0.3 62 K
Other Assets 0 0 0 0 0 0 0 0
Total Assets 221.2 299.6 217.9 151.8 89.5 114.7 54.2 11.4
LIABILITIES
Accounts Payable 8.3 2.5 2.0 2.4 0.8 0.2 0.5 0.5
Short Term Debt 6.0 5.1 2.4 2.1 1.8 0 0 0
Other Current Liabilities 3.5 3.4 3.8 2.0 3.4 3.1 0.9 0.2
Total Current Liabilities 17.7 11.0 8.2 6.4 6.0 3.3 1.5 0.7
Long Term Debt 15.9 18.7 12.8 8.8 10.9 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 (4.4) (5.5) 2.5 78.4 28.2
Total Liabilities 33.7 29.7 21.1 10.9 11.5 5.9 79.9 28.9
EQUITY
Common Stock 73 K 68 K 56 K 46 K 19 K 19 K 1 K 1 K
Retained Earnings (350.8) (248.9) (180.7) (126.0) (84.3) (49.2) (26.0) (17.5)
Other Accumulative Comprehensive Income/Loss (0.1) (0.9) (0.3) (0.1) (0.2) (0.2) (0.1) (0.1)
Total Equity 187.6 269.9 196.9 141.0 78.0 108.8 (25.7) (17.4)
Total Liabilities and Equity 221.2 299.6 217.9 151.8 89.5 114.7 54.2 11.4
SHARES OUTSTANDING
Common Shares Outstanding 72.6 67.4 52.8 44.0 19.1 10.3 13.0 13.0